Developer of a plant breeding platform designed to build a new and more sustainable food system.
Developer of a plant breeding platform designed to build a new and more sustainable food system.
Other Agriculture📍 Cambridge, MAFounded 2016
Current Valuation
$1.6B
as of 2025-Q1
UNICORN
QL Price
$1.6B
0% vs last round
QuantLogix's current estimate for Inari, published 2026-09-27 — in line with the last disclosed round of $1.6B (2025-Q1).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$1.6B
2025-Q1
weight 0.36
Secondary market print
$1.6B
2026-06-27
weight 0.58
How this price has held up
No round has priced for Inari since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Inari, 2026-09-27 (1ddec13d935db379).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Inari going public?
No. Inari is private and has not filed to go public. There is no S-1 on file.
What is Inari's valuation in 2026?
Inari is valued at $1.6B as of 2025-Q1, set by its Later Stage VC ($144M, Jan 2025). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Inari filed an S-1?
No public S-1 is on file for Inari.
How much has Inari raised?
Inari has raised $771M in total, most recently a Later Stage VC of $144M in Jan 2025.
Is Inari publicly traded — can you buy Inari stock?
No. Inari is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Inari on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2016
HQ
Cambridge, MA
Employees
300
Total Raised
$771M
Last Round
Later Stage VC — $144M (Jan 2025)
IPO Status
private
Fundraising Status
Later Stage VC · $144M · 1y 8mo ago
privateTotal raised $771M
Secondary Market
Implied price / share
$8
Open interest
1
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Later Stage VC
$144M
Jan 2025
—
$1.6B
Vertical Intelligence — Biotech / Gene Therapy
No name-verified sponsor record on ClinicalTrials.gov for Inari — trials may run under a different legal entity, a partner sponsor, or not yet exist. Absence of a registry match is reported as-is, never guessed around.
Checked clinicaltrials.gov as of 2026-09-27. Re-checked weekly.
Talent Signal
Hiring trend
▲ Hiring uptrend
+67% vs 2026-08
Open roles
5
via workday
Product-build share
40%
engineering, research, product, design
Trajectory
scaling
balanced build + GTM — 40% builders vs 60% go-to-market/G&A — scaling both sides.
Executive bench growing while hiring expands: 1 senior hire (CEO); open roles trending up.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Key Executive Moves
INLisa Nunez SafarianCEO · 2026-09-16
From trusted-source news extraction (deep-enrich pipeline); dates approximate publication, not effective date.
Research Associate, Sampling and DNA ExtractionSr Staff Platform Engineer / Team LeadSr Manager, AIDirector, CybersecuritySVP, Strategy and Business Development
Counted from Inari's live job board as of 2026-09-16; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
AgricultureAgTechBiotechnology
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2025-Q1. Refreshed quarterly.